Somewhere in the world, someone desperately needs specific medication to improve or save their life, while elsewhere, this medication has been approved and is accessible. Unfortunately, this disconnect is all too common. Ikris Pharma Network (IPN) aims to bridge that gap. Almost all have been impacted by this situation on a personal level, and we understand that our loved ones, patients, and everyone else deserve the opportunity for a better life. Early access programs in India, Brazil, Bulgaria, Germany, and other countries are a means to achieve this, and we are making our mark by connecting people to those opportunities.

In many countries, patients with long-lasting, life-threatening, or seriously debilitating diseases have the right to access, purchase, and import potentially life-saving medicines or those that improve the quality of life. Each nation has its specific rules and regulations governing the access and import of advanced medicines, with programs like the Named Patient Import, Early Access Programme, and Compassionate Use Programme. In countries like Brazil, the Medicine Access Program allows patients to access essential drugs that are not locally available. In India, the Managed Access Programs are designed to help patients get advanced medications through legal channels.

Managed Access Program Supplier- Ikris Pharma

Ikris Pharma Network is a legally recognized company operating in over 150 countries, having served thousands of patients to date. We adhere to a strict set of rules established by Ministries of Health, Named Patient-type programs, and customs agencies worldwide. We carefully select suppliers based on product quality and their ability to manage reliable stock. We also negotiate to secure the lowest prices to pass these savings on to the patients we support.

As one of the leading Named patient program suppliers in India and other countries, we recognize that we are entering a new frontier. By offering in-depth information on this subject, we aim to educate patients globally so they understand their potential to effect positive change.

At Ikris Pharma Network (IPN), our mission is to be a portal ensuring that every individual, regardless of location or status, has fast, fair access to advanced healthcare. We work with individual patients on a Named Patient import basis, in collaboration with their healthcare professionals. We assist them in accessing life-saving medicines when certain criteria are met:

• The medication has market approval in another country but is unapproved or unavailable in the patient’s home country.
• There are no alternative treatments on the market.
• The medication is for personal use.
• The patient has a valid prescription letter from their doctor in their home country.

Through the Named Patient Import Service we provide, we encourage patients to consult their doctors to determine the best course of treatment. Once we receive a valid prescription letter, we verify the information and manage all subsequent steps: from sourcing and shipping to customs and delivery, as well as follow-up to ensure that everything was received correctly.